Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

Filiz Cebeci, İlkay Kartal

10.1136/ejhpharm-2021-002794

May 24, 2021

CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions

Ha Thi Vo, Bruno Charpiat, Sebastien Chanoine, Michel Juste, Renaud Roubille, François-Xavier Rose, Ornella Conort, Benoît Allenet, Pierrick Bedouch

10.1136/ejhpharm-2020-002642

April 21, 2021

Editor's choice

The CLEO assessment tool for pharmacist interventions

Tommy Eriksson

10.1136/ejhpharm-2021-002882

June 23, 2021

Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis

Sakae Fukushima, Manami Oishi, Hiroya Aso, Kifumi Arai, Yuuki Sasaki, Naohiro Tochikura, Susumu Ootsuka, Noriyasu Fukuoka, Nobuhiro Ooba, Norikazu Kikuchi

10.1136/ejhpharm-2021-002739

June 28, 2021

Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19

Raquel Moreno Diaz, Miguel Angel Amor García, Francisco Javier Teigell Muñoz, Leonardo Ernesto Saldaña Perez, María Mateos Gonzalez, Jose Antonio Melero Bermejo, Alberto López Hernández, Laura Reyes Marquez, Maria Teresa De Guzman García-Monge, Jose Luis Perez Quero, Marcela Patricia Homez Guzman

10.1136/ejhpharm-2020-002669

February 24, 2021

The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study

Elien B Uitvlugt, Danny Y F Soeng, Paul van der Linden, Ewoudt M W van de Garde

10.1136/ejhpharm-2021-002781

July 16, 2021

Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System

Alma Mulac, Katja Taxis, Ellen Hagesaether, Anne Gerd Granas

10.1136/ejhpharm-2020-002298

June 23, 2020

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice

Frits A Boom, Paul P H Le Brun, Judith M Ris, Tjitske Veenbaas, Daan Touw

10.1136/ejhpharm-2021-002747

July 7, 2021

Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?

Nadir Yalçın, Sertaç Ak, Kutay Demirkan

10.1136/ejhpharm-2020-002419

July 3, 2020

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients

Rubén Iglesias Gómez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías Vericat, Eduardo López-Briz, Isabel Font-Noguera, Rosario Menéndez Villanueva, José Andrés Román Iborra, José Luis Poveda Andrés

10.1136/ejhpharm-2021-002741

July 28, 2021